{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T08:35:07Z","timestamp":1783067707507,"version":"3.54.6"},"update-to":[{"DOI":"10.1002\/14651858.cd008453","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2011,11,9]],"date-time":"2011-11-09T00:00:00Z","timestamp":1320796800000}}],"reference-count":23,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008453.pub2","type":"journal-article","created":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T14:19:23Z","timestamp":1320157163000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Helicobacter pylori eradication for Parkinson's disease"],"prefix":"10.1002","volume":"2011","author":[{"given":"Karen","family":"Rees","sequence":"first","affiliation":[{"name":"Warwick Medical School, University of Warwick; Division of Health Sciences; Coventry UK CV4 7AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Stowe","sequence":"additional","affiliation":[{"name":"University of Birmingham; Birmingham Clinical Trials Unit; Edgbaston Birmingham UK B15 2TT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smitaa","family":"Patel","sequence":"additional","affiliation":[{"name":"University of Birmingham; Birmingham Clinical Trials Unit; Edgbaston Birmingham UK B15 2TT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Ives","sequence":"additional","affiliation":[{"name":"University of Birmingham; Birmingham Clinical Trials Unit; Edgbaston Birmingham UK B15 2TT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieran","family":"Breen","sequence":"additional","affiliation":[{"name":"Parkinson's Disease Society; Research and Development Directorate; 215 Vauxhall Bridge Road London UK SW1V 1EJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl E","family":"Clarke","sequence":"additional","affiliation":[{"name":"College of Medicine and Dental Sciences; School of Clinical and Experimental Medicine; University of Birmingham Edgbaston Birmingham West Midlands UK B18 7QH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoav","family":"Ben-Shlomo","sequence":"additional","affiliation":[{"name":"Canynge Hall; Dept of Social Medicine; Whiteladies Road Bristol UK BS8 2PR"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,11,9]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD008453.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1523-5378.2005.00330.x","article-title":"Role of chronic infection and inflammation in the gastrointestinal tract in the etiology and pathogenesis of idiopathic parkinsonism. Part 2: response of facets of clinical idiopathic parkinsonism to Helicobacter pylori eradication. A randomized, double-blind, placebo-controlled efficacy study","volume":"10","author":"Bjarnason","year":"2005","journal-title":"Helicobacter"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD008453.pub2-BIB0002|cit2","first-page":"20","article-title":"Fulfilment of hypothesis: a direct, or surrogate, not necessarily unique, role for Helicobacter infection in the pathogenesis of idiopathic Parkinsonism","volume":"4","author":"Dobbs","year":"2007","journal-title":"Neuro-degenerative Diseases"},{"issue":"4","key":"10.1002\/14651858.CD008453.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1523-5378.2010.00768.x","article-title":"Differential effect of Helicobacter pylori eradication on time-trends in brady hypokineasia and rigidity in idiopathic parkinsonism: Report on completion of a randomized, double-blind, placebo-controlled efficacy study","volume":"15","author":"Dobbs","year":"2010","journal-title":"Helicobacter"},{"issue":"12","key":"10.1002\/14651858.CD008453.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1212\/01.wnl.0000221672.01272.ba","article-title":"Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations","volume":"66","author":"Pierantozzi","year":"2006","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD008453.pub2-BIB0005|cit5","unstructured":"Treating H. Pylori in Parkinson's patients with motor fluctuations ClinicalTrials.gov NCT00664209"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD008453.pub2-BIB0006|cit6","first-page":"S312","article-title":"Helicobacter pylori eradication improves treatment response in advanced Parkinson's disease with motor fluctuations","volume":"23","author":"Borgohain","year":"2008","journal-title":"Movement Disorders"},{"issue":"12","key":"10.1002\/14651858.CD008453.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1002\/mds.22190","article-title":"Helicobacter pylori infection and motor fluctuations in patients with Parkinson's disease","volume":"23","author":"Lee","year":"2008","journal-title":"Movement Disorders"},{"issue":"5","key":"10.1002\/14651858.CD008453.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/ana.1267","article-title":"Helicobacter pylori-induced reduction of acute levodopa absorption in Parkinson's disease patients","volume":"50","author":"Pierantozzi","year":"2001","journal-title":"Annals of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD008453.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s100720170061","article-title":"Reduced L-dopa absorption and increased clinical fluctuations in Helicobacter pylori-infected Parkinson's disease patients","volume":"22","author":"Pierantozzi","year":"2001","journal-title":"Neurological Sciences"},{"issue":"9","key":"10.1002\/14651858.CD008453.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1046\/j.1365-2036.2000.00815.x","article-title":"Parkinsonism: differential age-trend in Helicobacter pylori antibody","volume":"14","author":"Dobbs","year":"2000","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD008453.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ana.410210409","article-title":"Levodopa pharmacokinetic mechanisms and motor fluctuations in Parkinson's disease","volume":"21","author":"Fabbrini","year":"1987","journal-title":"Annals of Neurology"},{"issue":"6","key":"10.1002\/14651858.CD008453.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/0016-5085(91)90644-Z","article-title":"Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race and socioeconomic status","volume":"100","author":"Graham","year":"1991","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1002\/14651858.CD008453.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"770","DOI":"10.7326\/0003-4819-116-9-705","article-title":"Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study","volume":"116","author":"Graham","year":"1992","journal-title":"Annals of Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD008453.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/mds.1203","article-title":"Gastric emptying time and gastric motility in patients with Parkinson's Disease","volume":"16","author":"Hardoff","year":"2001","journal-title":"Movement Disorders"},{"issue":"6","key":"10.1002\/14651858.CD008453.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/ana.410230611","article-title":"Duodenal and gastric delivery of levodopa in parkinsonism","volume":"23","author":"Kurlan","year":"1988","journal-title":"Annals of Neurology"},{"key":"10.1002\/14651858.CD008453.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2036.2008.03906.x","article-title":"Systematic review: Helicobacter pylori infection and impaired drug absorption","volume":"29","author":"Lahner","year":"2009","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD008453.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.mehy.2009.11.001","article-title":"Microbial endocrinology as a basis for imporoved L-DOPA bioavailability in Parkinson's patients treated for Helicobacter Pylori","volume":"74","author":"Lyte","year":"2010","journal-title":"Medical Hypotheses"},{"issue":"10","key":"10.1002\/14651858.CD008453.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1211\/jpp.61.10.0005","article-title":"In-vitro interaction of L-dopa with bacterial adhesins of Helicobacter pylori: an explanation for clinical differences in bioavailability?","volume":"61","author":"Niehues","year":"2009","journal-title":"The Journal of Pharmacy and Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD008453.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2174\/138955708783498177","article-title":"Helicobacter pylori interference with micronutrients and orally administered drugs: a new mechanism explaining its role in extragastric disorders","volume":"8","author":"Pietroiusti","year":"2008","journal-title":"Mini-Reviews in Medicinal Chemistry"},{"issue":"7392","key":"10.1002\/14651858.CD008453.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/bmj.326.7392.737","article-title":"Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review","volume":"326","author":"Raghunath","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD008453.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2169\/internalmedicine.32.359","article-title":"The relationship between Helicobacter pylori and oxygen derived free radicals in the mechanism of duodenal ulceration","volume":"32","author":"Salim","year":"1993","journal-title":"Internal Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD008453.pub2-BIB0022|cit22","first-page":"S291","article-title":"Prevalence of Helicobacter pylori infection among patients with Parkinson's disease: impact on clinical manifestations","volume":"23","author":"Tsuboi","year":"2008","journal-title":"Movement Disorders"},{"issue":"89","key":"10.1002\/14651858.CD008453.pub2-BIB0023|cit23","first-page":"428","article-title":"Infection of Helicobacter pylori and its influence on Parkinson's disease","volume":"15","author":"Wlodarek","year":"2003","journal-title":"Polski Merkuriusz Lekarski"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD008453.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:29:11Z","timestamp":1777462151000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD008453.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Movement Disorders Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,11,9]]},"references-count":23,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2011,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008453.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,9]]}}}